Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 1
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Bisphosphonate - Induced Nephropathy"
Page 1
Interventions for preventing bone disease in kidney transplant recipients.
Palmer SC, McGregor DO, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005015. doi: 10.1002/14651858.CD005015.pub3. Cochrane Database Syst Rev. 2007. PMID: 17636784 Review.
Date of last search: May 2006 SELECTION CRITERIA: RCTs and quasi-RCTs comparing different treatments for kidney transplant recipients of any age were selected. We excluded all other transplant recipients, including kidney-pancreas transplant recipients. ...Other out …
Date of last search: May 2006 SELECTION CRITERIA: RCTs and quasi-RCTs comparing different treatments for kidney transplant recipients …
Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
Wang J, Yao M, Xu JH, Shu B, Wang YJ, Cui XJ. Wang J, et al. Osteoporos Int. 2016 May;27(5):1683-90. doi: 10.1007/s00198-015-3465-7. Epub 2016 Jan 5. Osteoporos Int. 2016. PMID: 26733377 Review.
We conducted a systematic review of randomized controlled trials (RCTs) of bisphosphonates for the prevention of osteopenia in kidney-transplant recipients. ...However, there is currently no widely recognized strategy for the prevention of corticosteroid-induced …
We conducted a systematic review of randomized controlled trials (RCTs) of bisphosphonates for the prevention of osteopenia in kid …
Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF. Palmer SC, et al. Am J Kidney Dis. 2015 Dec;66(6):962-71. doi: 10.1053/j.ajkd.2015.03.036. Epub 2015 May 21. Am J Kidney Dis. 2015. PMID: 26003472 Free article. Review.
INTERVENTION: Drug interventions with effects on serum PTH, phosphorus, and calcium levels, including vitamin D compounds, phosphate binders, cinacalcet, bisphosphonates, and calcitonin. OUTCOMES: Correlation between drug effects on biochemical and all-cause and cardiovasc …
INTERVENTION: Drug interventions with effects on serum PTH, phosphorus, and calcium levels, including vitamin D compounds, phosphate binders …
Prevention of steroid-induced low bone mineral density in children with renal diseases: a systematic review.
Gruppen MP, Davin JC, Oosterveld MJ, Schreuder MF, Dorresteijn EM, Kramer SP, Bouts AH. Gruppen MP, et al. Nephrol Dial Transplant. 2013 Aug;28(8):2099-106. doi: 10.1093/ndt/gft090. Epub 2013 May 2. Nephrol Dial Transplant. 2013. PMID: 23640430 Review.
However, there is no common strategy for prevention of corticosteroid-induced osteoporosis. The present systematic review was performed to determine whether prevention of bone loss by calcium (Ca), vitamin D (vit D) and/or bisphosphonates is justified, safe and effi …
However, there is no common strategy for prevention of corticosteroid-induced osteoporosis. The present systematic review was perform …